147 related articles for article (PubMed ID: 8774129)
1. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.
Bohle RM; Brettreich S; Repp R; Borkhardt A; Kosmehl H; Altmannsberger HM
Am J Pathol; 1996 Mar; 148(3):731-8. PubMed ID: 8774129
[TBL] [Abstract][Full Text] [Related]
2. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
[TBL] [Abstract][Full Text] [Related]
3. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2001 Nov; 32(11):1225-31. PubMed ID: 11727262
[TBL] [Abstract][Full Text] [Related]
4. H-ras-1 point mutations in soft tissue sarcomas.
Wilke W; Maillet M; Robinson R
Mod Pathol; 1993 Mar; 6(2):129-32. PubMed ID: 8483882
[TBL] [Abstract][Full Text] [Related]
5. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients.
Yoo J; Robinson RA
Cancer; 1999 Jul; 86(1):58-63. PubMed ID: 10391564
[TBL] [Abstract][Full Text] [Related]
6. H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes.
Yoo J; Robinson RA; Lee JY
Mod Pathol; 1999 Aug; 12(8):775-80. PubMed ID: 10463479
[TBL] [Abstract][Full Text] [Related]
7. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
8. Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations.
Rieske P; Bartkowiak J; Szadowska A; Debiec-Rychter M
Mol Pathol; 1999 Apr; 52(2):64-7. PubMed ID: 10474683
[TBL] [Abstract][Full Text] [Related]
9. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing.
Tada M; Omata M; Ohto M
Cancer Res; 1990 Feb; 50(4):1121-4. PubMed ID: 2153451
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
11. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
[TBL] [Abstract][Full Text] [Related]
12. [Detection of point mutation of p53 gene by silver staining PCR-SSCP in paraffin-embedded malignant fibrous histiocytoma].
Li J; Yang G; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):13-5. PubMed ID: 8732103
[TBL] [Abstract][Full Text] [Related]
13. The rise and fall of malignant fibrous histiocytoma.
Erlandson RA; Antonescu CR
Ultrastruct Pathol; 2004; 28(5-6):283-9. PubMed ID: 15764577
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Adachi T; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Arch Pathol Lab Med; 2002 Sep; 126(9):1071-8. PubMed ID: 12204056
[TBL] [Abstract][Full Text] [Related]
15. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.
Larramendy ML; Tarkkanen M; Blomqvist C; Virolainen M; Wiklund T; Asko-Seljavaara S; Elomaa I; Knuutila S
Am J Pathol; 1997 Oct; 151(4):1153-61. PubMed ID: 9327749
[TBL] [Abstract][Full Text] [Related]
17. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
18. High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas.
Ohashi K; Tsutsumi M; Nakajima Y; Noguchi O; Okita S; Kitada H; Tsujiuchi T; Kobayashi E; Nakano H; Konishi Y
Jpn J Clin Oncol; 1994 Dec; 24(6):305-10. PubMed ID: 7830335
[TBL] [Abstract][Full Text] [Related]
19. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
20. SAS amplification in soft tissue sarcomas.
Smith SH; Weiss SW; Jankowski SA; Coccia MA; Meltzer PS
Cancer Res; 1992 Jul; 52(13):3746-9. PubMed ID: 1319830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]